NCT07322705

Brief Summary

The goal of this clinical trial is to analyze the impact of perineal post-free traction versus traditional perineal post traction on perineal complications in hip arthroscopy. The main question it aims to answer is:

  • Can Perineal Post-Free Traction in Hip Arthroscopy Effectively Reduce Perineal Complications? Researchers will compare the perineal-post-free traction group with the conventional perineal-post traction group to see if the former decreases perineal complications and improves efficiency without compromising surgical outcomes. Participants will:
  • Undergo either perineal-post-free or standard perineal-post traction during hip arthroscopy
  • Complete nerve-injury checks on day 1 and at discharge, and hip-function questionnaires (VAS, mHHS, IHOT-12, HOS) at 3 months
  • Allow collection of operating times, hospital stay, and direct medical costs for economic analysis

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
270

participants targeted

Target at P75+ for not_applicable

Timeline
5mo left

Started Jan 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress45%
Jan 2026Sep 2026

First Submitted

Initial submission to the registry

November 17, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 7, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

January 7, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Last Updated

January 7, 2026

Status Verified

December 1, 2025

Enrollment Period

6 months

First QC Date

November 17, 2025

Last Update Submit

December 23, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The incidence of perineal nerve injury

    The incidence of perineal nerve injury included: perineal numbness, pain, soft tissue injury, sexual function and urinary dysfunction.sexual function and urinary dysfunction.

    The first day after surgery

Secondary Outcomes (12)

  • The incidence of pain, numbness, soft tissue injury in other places

    The first day after surgery

  • Patients at discharge perineum area incidence of nerve injury

    7 days after surgery

  • Intraoperative traction time

    During surgery (intraoperatively)

  • Preoperative preparation time

    Immediately before surgery (preoperatively)

  • Operating time

    During surgery (intraoperatively)

  • +7 more secondary outcomes

Study Arms (2)

Perineal Post-Free Traction

EXPERIMENTAL
Procedure: Perineal Post-Free Traction

Perineal Post Traction

ACTIVE COMPARATOR
Procedure: Perineal Post Traction

Interventions

Traction achieved with a thoraco-abdominal belt and contralateral groin strap; operating table tilted 10-15° Trendelenburg; gradual 10-20 kg distraction under fluoroscopy to 8-10 mm joint space. No perineal post is used, eliminating direct perineal pressure.

Perineal Post-Free Traction

Standard traction table with padded perineal post placed against the groin providing counter-traction; affected limb distracted under fluoroscopy to 8-10 mm joint space while contralateral limb is abducted.

Perineal Post Traction

Eligibility Criteria

Age15 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Aged 15 to 60 years;
  • Met the diagnostic criteria of femoroacetabular impingement syndrome (FAI) and indicated for hip arthroscopy based on patient history, symptoms, signs, physical examination, imaging (pelvic anteroposterior view, frog-leg view, CT 3D reconstruction, MRI), and diagnostic injections;
  • Able to read and sign the informed consent form.

You may not qualify if:

  • History of high-energy hip trauma, previous ipsilateral or contralateral hip surgery, avascular necrosis of the femoral head, slipped capital femoral epiphysis, Perthes disease, severe osteoporosis, tumors, acetabular stress fractures, or proliferative or immune hip diseases;
  • Diseases causing groin numbness, foot numbness, sexual dysfunction, urinary dysfunction, skin injuries, perineal injuries, nerve injuries, radicular pain, inner or outer thigh numbness;
  • Abnormal heart, lung, liver, kidney function, severe coagulation disorders, poorly controlled diabetes, judged by the researcher to have an infection risk;
  • Consciousness disorders, psychiatric disorders, or neuromuscular dysfunction affecting lower limb function;
  • Active infection foci (systemic or local infectious lesions);
  • Pregnancy, lactation, or planned pregnancy during the clinical study period;
  • Participation in another clinical trial within the past 3 months;
  • Patients deemed unsuitable for the clinical trial by the researcher for other reasons.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Femoracetabular Impingement

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Director of the Department of Sports Medicine

Study Record Dates

First Submitted

November 17, 2025

First Posted

January 7, 2026

Study Start

January 7, 2026

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

January 7, 2026

Record last verified: 2025-12